- Nilutamide, sold
under the
brand names Nilandron and
Anandron, is a
nonsteroidal antiandrogen (NSAA)
which is used in the
treatment of
prostate cancer...
-
Tournemine C,
Raynaud JP (January 1986). "Pharmacology of an antiandrogen,
anandron, used as an
adjuvant therapy in the
treatment of
prostate cancer". Journal...
-
enzymes and
hepatotoxicity and the
availability of
safer agents.
Nilutamide (
Anandron, Nilandron):
Marketed for the
treatment of
prostate cancer. Very little-used...
- (tiaprofenic acid)
Claforan (cefotaxime sodium) Mi****yne (mifepristone, RU-486)
Anandron (nilutamide)
Revenue US$ 3.01
billion (1996) Net
income US$ 340 million(1996)...
-
anakinra (INN) Analpram-HC
AnaMantle HC
Anamine Syrup anamorelin (USAN, INN)
Anandron Anaprox anaritide (INN)
Anaspaz anastrozole (INN)
Anatrast anatumomab mafenatox...
-
include the first-generation
medications flutamide (Eulexin),
nilutamide (
Anandron, Nilandron), and
bicalutamide (Casodex).: 477
Newer and even more efficacious...
- Peereboom-Wynia JD (1989). "Reduction in
undesired ****ual hair
growth with
anandron in male-to-female trans****uals—experiences with a
novel androgen receptor...
- Peereboom-Wynia JD (September 1989). "Reduction in
undesired ****ual hair
growth with
anandron in male-to-female trans****uals--experiences with a
novel androgen receptor...
-
Lefebvre FA, Bélanger A,
Labrie F (1984). "The pure
antiandrogen RU 23908 (
Anandron), a
candidate of
choice for the
combined antihormonal treatment of prostatic...
-
ocular defects which have been seen with the
antiandrogen nilutamide (
Anandron, Roussel).
Fradet Y (February 2004). "Bicalutamide (Casodex) in the treatment...
